The Hippo Transducer YAP/TAZ as a Biomarker of Therapeutic Response and Prognosis in Trastuzumab-Based Neoadjuvant Therapy Treated HER2-Positive Breast Cancer Patients

BACKGROUND: We explored the therapeutic and prognostic effect of YAP/TAZ intensityinHER2-positive breast cancer patients. We also investigated the relationship between YAP/TAZ expression and Trastuzumab-resistance. METHODS: We collected clinicopathological information from 397 cases. We evaluated th...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Jia-qi, Ding, Nian-hua, Xiao, Zhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481481/
https://www.ncbi.nlm.nih.gov/pubmed/32973536
http://dx.doi.org/10.3389/fphar.2020.537265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481481/
https://www.ncbi.nlm.nih.gov/pubmed/32973536
http://dx.doi.org/10.3389/fphar.2020.537265

Ejemplares similares